Representation and warranty insurance was supposed to simplify private M&A. A buyer pays a premium, a carrier takes on the seller's indemnity exposure, and everyone walks away from closing without years of escrow holdbacks. That arrangement held for most of the last decade. In 2026, the product is still everywhere (it appears in the majority of US private transactions above $20 million), but the carrier posture has shifted meaningfully, and sellers who treat RWI as a procedural formality are getting tripped up.
Under the traditional model, RWI (also called reps and warranties insurance) covered the seller's representations in the purchase agreement for a defined period after closing, typically three years for general reps and six years for fundamental items like title and tax. The buyer would cap seller indemnity at a small percentage of deal value, the policy would pick up losses above that cap, and the carrier's role was largely passive: underwrite the policy, collect the premium, handle claims if they arose.
The shift over the last eighteen months has been gradual but real. Carriers are no longer passive. Underwriters now routinely participate in diligence calls on key risk areas, negotiate directly with buyer and seller counsel over policy language, and engage early in the deal rather than at the post-term-sheet stage. Their goal is to shape the risk before it is allocated, not to absorb whatever comes out of the negotiation.
The first change is timing. Carriers want to be brought in during the early diligence phase, not after the purchase agreement is mostly negotiated. That means sellers and their advisors need to align on a risk narrative earlier in the process. If the carrier sees unresolved red flags in the data room, they push for exclusions or carve-backs that the buyer then passes down into the indemnity structure.
The second change involves interim period mechanics. In transactions where signing and closing are separated by a long period, usually due to regulatory review in healthcare, energy, or cross-border deals, policy language is being actively adjusted. For interim periods between twelve and eighteen months, carriers are reinserting Material Adverse Effect language synthetically into the representations. For interim periods longer than eighteen months, they are effectively ignoring double-materiality scrapes altogether. The result is a narrower policy than the purchase agreement text suggests on its face.
The third change is industry-specific scrutiny. Healthcare, energy, and certain regulated sectors are drawing extra underwriter attention because government review timelines have stretched and enforcement posture has become less predictable. Sellers in those sectors should expect more questions about compliance history, more pressure on specific reps, and sometimes a refusal to cover certain categories of risk outright.

Industry data from the last two years shows stable claim frequency but rising severity. The dollars involved per claim are higher, the use of multiplied damage theories has increased, and financial statement claims continue to represent the largest category of loss. Carriers are responding not by raising premiums across the board (the market is still competitive) but by tightening language, sharpening exclusions, and pushing harder on diligence during underwriting.
For sellers, the practical implication is that a smooth RWI process is no longer automatic. If your QoE report is weak, if your tax position has unaddressed exposure, or if your compliance documentation has gaps, the carrier will find those issues and they will be priced into either the premium, the exclusion list, or the portion of liability the buyer keeps in the indemnity cap.
Buyers benefit from the carrier's more active posture, but only partially. On the positive side, having the carrier involved early forces both sides to confront risk issues before the agreement is drafted, which reduces post-closing disputes and speeds up the final negotiation. On the negative side, carrier pushback on policy language means the buyer's nominal indemnity protection may not match the purchase agreement text, especially on long-tail interim period deals. Buyers need to read the policy carefully against the agreement and understand where the gaps sit.
The other practical point for buyers is that the cost-benefit of RWI has shifted slightly. Premiums remain in a historically reasonable range, but the scope of what is actually covered has narrowed in several dimensions. For deals where the buyer is already doing extensive diligence and the seller has a clean profile, RWI still makes sense. For deals with significant complexity or ambiguous risk areas, buyers should do the math on whether a traditional indemnity with escrow might actually provide better real-world protection.
Two developments will shape RWI over the next year. The first is the claims pipeline from 2022-era deals, which is now working through the courts and will produce coverage decisions that clarify what carriers will and will not pay for. The second is the carrier appetite for AI-related representations, a genuinely new category of risk where underwriters are still figuring out how to price uncertainty around training data, model outputs, and intellectual property claims. Both will influence where RWI premiums and exclusions settle by the end of 2026.
Representation and warranty insurance is still the default liability transfer mechanism in private M&A, but the product has matured into something more active and more negotiated than it was five years ago. For sellers, that means preparation matters more, not less. The carrier is now part of the diligence process, not a downstream formality, and the cleanest path to a smooth policy is a clean business with well-organized records and a credible sell-side QoE on the table before buyers start looking.